Pages that link to "Q48427709"

The following pages link to Permeability of the blood-cerebrospinal fluid and blood-brain barriers to thyrotropin-releasing hormone (Q48427709):

Displaying 40 items.

• The pericyte: a forgotten cell type with important implications for Alzheimer's disease? (Q26852369) (← links)
• Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease (Q28087176) (← links)
• A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease (Q28261647) (← links)
• Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders (Q29615839) (← links)
• Focused ultrasound-mediated drug delivery through the blood-brain barrier (Q30394357) (← links)
• Impaired Lipoprotein Receptor-Mediated Peripheral Binding of Plasma Amyloid-β is an Early Biomarker for Mild Cognitive Impairment Preceding Alzheimer's Disease (Q33895840) (← links)
• Targeting drugs to the brain by redox chemical delivery systems. (Q33996838) (← links)
• Kinetic analysis of leucine-enkephalin cellular uptake at the luminal side of the blood-brain barrier of an in situ perfused guinea-pig brain (Q34047764) (← links)
• Measurement of solute transport across the blood-brain barrier in the perfused guinea pig brain: method and application to N-methyl-alpha-aminoisobutyric acid (Q34048892) (← links)
• Low‐density lipoprotein receptor‐related protein‐1: a serial clearance homeostatic mechanism controlling Alzheimer’s amyloid β‐peptide elimination from the brain (Q34274025) (← links)
• Prenatal treatment with thyrotrophin releasing hormone to prevent neonatal respiratory distress (Q35066869) (← links)
• Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's disease (Q35559895) (← links)
• Exploratory neuropharmacological evaluation of a conformationally constrained thyrotropin-releasing hormone analogue (Q38636054) (← links)
• Low-density lipoprotein receptor-related protein 1: a physiological Aβ homeostatic mechanism with multiple therapeutic opportunities (Q36205039) (← links)
• HIV-1 Tat Regulates Occludin and Aβ Transfer Receptor Expression in Brain Endothelial Cells via Rho/ROCK Signaling Pathway (Q37176830) (← links)
• Prodrugs of thyrotropin-releasing hormone and related peptides as central nervous system agents (Q37391961) (← links)
• Use of TRH analogues in motorneurone disease (Q38224468) (← links)
• Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD). (Q38295848) (← links)
• Pericytes of the neurovascular unit: key functions and signaling pathways. (Q38844788) (← links)
• Age-associated physiological and pathological changes at the blood-brain barrier: A review. (Q39005977) (← links)
• Brain metabolism in health, aging, and neurodegeneration (Q39259780) (← links)
• Selective antihypertensive dihydropyridines lower Aβ accumulation by targeting both the production and the clearance of Aβ across the blood-brain barrier (Q39618144) (← links)
• Cerebrovascular permeability to peptides: manipulations of transport systems at the blood-brain barrier (Q40960259) (← links)
• Chronic vascular risk factors (cholesterol, homocysteine, ethanol) impair spatial memory, decline cholinergic neurons and induce blood-brain barrier leakage in rats in vivo (Q41627968) (← links)
• Comparative antidepressant effects of intravenous and intrathecal thyrotropin-releasing hormone: confounding effects of tolerance and implications for therapeutics. (Q42649389) (← links)
• PEPT2-mediated uptake of neuropeptides in rat choroid plexus (Q43689079) (← links)
• Design, synthesis, and biological evaluation of novel, centrally-acting thyrotropin-releasing hormone analogues. (Q44071196) (← links)
• Synthesis and biological evaluations of brain-targeted chemical delivery systems of [Nva2]-TRH. (Q44090032) (← links)
• Triglyceride-rich lipoprotein lipolysis products increase blood-brain barrier transfer coefficient and induce astrocyte lipid droplets and cell stress (Q44646913) (← links)
• Permeability of the blood-brain barrier to the immunosuppressive cyclic peptide cyclosporin A. (Q46628726) (← links)
• Vascular degeneration in Parkinson's disease. (Q47256703) (← links)
• Disruption of Bmal1 Impairs Blood-Brain Barrier Integrity via Pericyte Dysfunction. (Q47799570) (← links)
• Passage of delta sleep-inducing peptide (DSIP) across the blood-cerebrospinal fluid barrier (Q48957895) (← links)
• Synergistic Memory Impairment Through the Interaction of Chronic Cerebral Hypoperfusion and Amlyloid Toxicity in a Rat Model (Q51000793) (← links)
• A mathematical model for prediction of drug molecule diffusion across the blood-brain barrier. (Q51982535) (← links)
• Neutral amino acid uptake by the isolated perfused sheep choroid plexus (Q69231974) (← links)
• Three approaches to pathophysiology of shock (Q80288510) (← links)
• Altered folate binding protein expression and folate delivery are associated with congenital hydrocephalus in the hydrocephalic Texas rat (Q88808744) (← links)
• Degradation of Extracellular Matrix by Matrix Metalloproteinase 2 Is Essential for the Establishment of the Blood-Brain Barrier in Drosophila (Q92721238) (← links)
• Localized Blood-Brain Barrier Opening in Ovine Model Using Image-Guided Transcranial Focused Ultrasound (Q92882225) (← links)